Incannex Healthcare Inc. (IXHL): Shareholders' Equity

Annual figures by period end, from SEC filings.

$67.37M
As of 2026-06-30
$66.14M
As of 2026-09-30
+47.9%
3-year compound annual growth
2023-06-30: $20.82M2024-06-30: $11.22M2025-06-30: $13.39M2026-06-30: $67.37M$67.37M
2023-06-30 Shareholders' Equity (USD) 2026-06-30
Period endedShareholders' EquityChange YoYSource filing
2026-06-30$67.37M+403.2%2026-09-25, Balance as of period end
2025-06-30$13.39M+19.4%2026-09-25, Balance as of period end
2024-06-30$11.22M-46.1%2025-09-29, Balance as of period end
2023-06-30$20.82Mn/a2024-09-30, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Incannex Healthcare Inc. (IXHL)2026-06-30$67.37M+403.2%
Abbott Laboratories (ABT)2025-12-31$52.13B+9.4%
Bristol Myers Squibb Co (BMY)2025-12-31$18.47B+13.1%
TherapeuticsMD, Inc. (TXMD)2025-12-31$26.88M-1.8%
Eli Lilly & Co (LLY)2025-12-31$26.54B+85.9%
Pfizer Inc (PFE)2025-12-31$86.78B-1.9%
Johnson & Johnson (JNJ)2025-12-28$81.54B+14.1%
Nature's Sunshine Products Inc (NATR)2025-12-31$161.55M+0.3%
Merck & Co., Inc. (MRK)2025-12-31$52.66B+13.6%

Compare IXHL, ABT, BMY, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗